SHG · Healthcare

Zhejiang Orient Gene Biotech Co Ltd (688298)

Medical Devices

Zhejiang Orient Gene Biotech Co Ltd (688298) is listed on SHG in the Healthcare sector. Industry: Medical Devices. As of 2026-03-29, reported market cap is $4.59B, P/E ratio is 18.00, net margin is -58.8%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Key metrics for 688298

Market cap
$4.59B
P/E ratio
18.00
Gross profit (TTM)
$958.99M
Net margin
-58.8%

Zhejiang Orient Gene Biotech Co Ltd (688298) — FAQ

What is Zhejiang Orient Gene Biotech Co Ltd's market cap?

Zhejiang Orient Gene Biotech Co Ltd (688298) has a reported market cap of $4.59B (data as of 2026-03-29).

What is 688298's P/E ratio?

The price-to-earnings (P/E) ratio for Zhejiang Orient Gene Biotech Co Ltd (688298) is 18.00 (data as of 2026-03-29).

Does Zhejiang Orient Gene Biotech Co Ltd pay a dividend?

Dividend yield is not available in the current snapshot for Zhejiang Orient Gene Biotech Co Ltd (688298). Check the MyAverix Finance app for the latest dividend data.

What sector is Zhejiang Orient Gene Biotech Co Ltd in?

Zhejiang Orient Gene Biotech Co Ltd (688298) is classified in the Healthcare sector (Medical Devices industry).

What exchange is 688298 listed on?

688298 is listed on SHG.

What is Zhejiang Orient Gene Biotech Co Ltd's net margin?

Zhejiang Orient Gene Biotech Co Ltd (688298) reports a net margin of -58.8% (data as of 2026-03-29).

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

App Store Google Play